Access cutting-edge cesarean delivery treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access cesarean delivery specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cesarean delivery treatment provided free
This is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either adjunctive azithromycin prophylaxis or to placebo. Both groups also will receive standard of care preoperative antibiotics (excluding azithromycin). The primary endpoint is a maternal infection composite defined as any one of the following up to 6 weeks postpartum: endometritis, wound infection, abscess, septic thrombosis
Sponsor: The George Washington University Biostatistics Center
Check if you qualify for this cesarean delivery clinical trial in New York, NY
If you're searching for cesarean delivery treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cesarean delivery specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.